AI Article Synopsis

  • Metabolic syndrome (MetS) affects over one third of US adults and is linked to non-alcoholic fatty liver disease (NAFLD), which isn't currently included in its traditional diagnosis.
  • A study analyzed data from over 46,000 individuals to see if including NAFLD in the MetS criteria (referred to as MetS2) improved the accuracy of identifying those with metabolic issues and predicting health risks.
  • The findings showed that MetS2 identified an additional 8% of individuals with metabolic risk and was significantly associated with higher all-cause and cardiovascular disease mortality, highlighting the importance of early intervention.

Article Abstract

Background/aims: Metabolic syndrome (MetS) affects over one third of the US adult population. Despite its close association with non-alcoholic fatty liver disease (NAFLD), the traditional definition of MetS does not account for the presence of NAFLD. The present study thus aims to evaluate the inclusion of NAFLD in the diagnostic criteria of metabolic syndrome on its accuracy of capturing individuals with metabolic dysregulation and its prediction of adverse events.

Methods: Data collected from NHANES between 1999 and 2018 was analysed. Clinical characteristics and outcomes between individuals with metabolic syndrome from both the American Heart Association/National Heart, Lung, and Blood Institute (MetS) and the study's proposed diagnostic criteria (MetS2) were evaluated. Outcomes in both groups were evaluated with multivariate analyses, and further subgroup analysis on individuals matched with Coarsened Exact Matching was performed.

Results: Of 46,184 individuals included, 32.54% and 40.54% fulfilled MetS and MetS2 criteria respectively. Considering NAFLD in the definition of metabolic syndrome, a further 8.00% (n = 3694) were included. MetS was significantly associated with all-cause (HR: 1.184, 95% CI: 1.110-1.263, p < 0.001) and cardiovascular disease (CVD) mortality (SHR: 1.288, 95% CI: 1.233-1.347, p < 0.001), and major adverse cardiovascular events (MACE). MetS2 was similarly associated with all-cause (HR: 1.175, 95% CI: 1.088-1.269, p < 0.001), CVD mortality (SHR: 1.283, 95% CI: 1.245-1.323, p < 0.001) and MACE.

Conclusion: Inclusion of NAFLD allows for identification a greater proportion of the population with metabolic risk. This allows for early intervention and potential to lift some burden off the global healthcare system.

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.17397DOI Listing

Publication Analysis

Top Keywords

metabolic syndrome
20
non-alcoholic fatty
8
fatty liver
8
liver disease
8
definition metabolic
8
diagnostic criteria
8
individuals metabolic
8
metabolic
6
syndrome
5
mets
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!